Wealthedge Investment Advisors LLC Raises Stock Position in Lam Research Corporation $LRCX

Wealthedge Investment Advisors LLC grew its stake in Lam Research Corporation (NASDAQ:LRCX) by 121.0% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 3,785 shares of the semiconductor company’s stock after purchasing an additional 2,072 shares during the period. Wealthedge Investment Advisors LLC’s holdings in Lam Research were worth $1,640,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Fideuram Asset Management Ireland dac purchased a new position in Lam Research during the 4th quarter worth approximately $10,035,000. Generali Investments Management Co LLC lifted its stake in Lam Research by 62.0% in the fourth quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock valued at $6,209,000 after buying an additional 13,878 shares during the last quarter. Rokos Capital Management LLP boosted its holdings in shares of Lam Research by 42.0% in the first quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock valued at $55,532,000 after acquiring an additional 76,840 shares during the period. Aware Super Pty Ltd as trustee of Aware Super acquired a new stake in shares of Lam Research in the first quarter valued at approximately $59,973,000. Finally, Krilogy Financial LLC grew its position in shares of Lam Research by 19.5% during the first quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after acquiring an additional 4,584 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Lam Research

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. The trade was a 17.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 80,441 shares of company stock valued at $27,614,296. Corporate insiders own 0.31% of the company’s stock.

Lam Research Stock Up 1.1%

LRCX opened at $310.53 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The business has a 50 day simple moving average of $338.53 and a 200-day simple moving average of $285.89. The stock has a market capitalization of $388.57 billion, a P/E ratio of 53.91, a P/E/G ratio of 1.22 and a beta of 1.84. Lam Research Corporation has a 12 month low of $94.11 and a 12 month high of $438.50.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The company had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same period in the previous year, the firm earned $1.33 EPS. The business’s revenue was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, equities analysts anticipate that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on LRCX. Weiss Ratings cut shares of Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, August 7th. Susquehanna reaffirmed a “positive” rating and issued a $475.00 target price (up from $385.00) on shares of Lam Research in a report on Tuesday, June 30th. Wall Street Zen downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a research note on Sunday, May 10th. Cantor Fitzgerald set a $500.00 price target on Lam Research and gave the stock an “overweight” rating in a report on Monday, June 29th. Finally, Zacks Research raised shares of Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $358.47.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.